guest ::
| Home > Publications database > Vaccines Targeting Numerous Coronavirus Antigens, Ensuring Broader Global Population Coverage: Multi-epitope and Multi-patch Vaccines |
| Home > Publications database > Vaccines Targeting Numerous Coronavirus Antigens, Ensuring Broader Global Population Coverage: Multi-epitope and Multi-patch Vaccines |
| Contribution to a book | PUBDB-2024-05653 |
; ;
2022
Springer US
New York, NY
ISBN: 978-1-0716-1884-4, 978-1-0716-1884-4 (electronic)
This record in other databases: 
Please use a persistent id in citations: doi:10.1007/978-1-0716-1884-4_7
Abstract: Challenges for Vaccinologists in the First Half of the Twenty First Century -- Principles in Immunology for the Design and Development of Vaccines -- Revisiting the Principles of Designing a Vaccine -- Status of COVID-19 Pandemic before the Administration of Vaccine -- mRNA Vaccines to Protect against Diseases -- Artificial Intelligence in Vaccine and Drug Design -- Vaccines Targeting Numerous Coronavirus Antigens, Ensuring Broader Global Population Coverage: Multi-Epitope and Multi-Patch Vaccines.-Use of Micro-computed Tomography to Visualize and Quantify COVID-19 Vaccine Efficiency in Free-breathing Hamsters -- Design of Replication-Competent VSV- and Ervebo-vectored Vaccines against SARS-CoV-2 -- CRISPR Engineering of Bacteriophage T4 to Design Vaccines against SARS-CoV-2 and Emerging Pathogens -- Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases -- Towards Determining the Epitopes of the Structural proteins of SARS-CoV-2 -- Development, production and characterization of hepatitis B subviral envelope particles as a third-generation vaccine -- Generation of CpG-Recoded Zika Virus Vaccine Candidates -- Salmonella Uptake into Gut-Associated Lymphoid Tissues: Implications for Targeted Mucosal Vaccine Design and Delivery -- Development of Human Recombinant Leptospirosis Vaccines -- Induction of T-cell Responses by Vaccination of a Streptococcus pneumoniae Whole Cell Vaccine -- Development of a Bacterial Nanoparticle Vaccine against Escherichia coli -- Construction of Novel Live Genetically Modified BCG Vaccine Candidates using Recombineering Tools -- An Update on Tuberculosis Vaccines -- Structure-Based Design of Diagnostics and Vaccines for Lyme Disease -- Development of a SONIX vaccine to protect against ehrlichiosis -- Development of the Anti-Leishmanial Vaccine -- In Silico Design of Recombinant Chimera T Cell Peptide Epitope Vaccines for Visceral Leishmaniasis -- Pre-clinical Assessment of the Immunogenicity of Experimental Leishmania Vaccines -- Production of Oral Vaccines Based on Retrovirus Virus-like Particles Pseudotyped with Protozoan-Surface Proteins -- A Fast-Track Phenotypic Characterization of Plasmodium falciparum Vaccine Antigens through Lyse-Reseal Erythrocytes Mediated Delivery (LyRED) of RNA Interference for Targeted Translational Repression -- Plasmodium falciparum Antigen Expression in Leishmania Parasite: A Way Forward for Live Attenuated Vaccine Development -- Molecular Characterization of a Vector-based Candidate Antigen using the 3'–RACE and Genome Walking Methods and In Silico Analysis of the Correspondent Protein for Vaccine Design and Development -- In vitro culture of Plasmodium falciparum for the Production of Mature Gametocytes for Performing Standard Membrane Feeding Assay and Infection of Anopheles spp. -- Plasmodium berghei Infection in BALB/c Mice Model as an Animal Model for Malaria Disease Research -- Standard membrane feeding assay for malaria transmission studies -- Generation of Tumor Targeted Dendritic Cell Vaccines with Improved Immunogenic and Migratory Phenotype -- Monocytes as a Cellular Vaccine Platform to Induce Anti-Tumor Immunity -- Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines -- Proteomics for Development of Food Allergy Vaccines -- Estimating Vaccine Potency using Antibody-based Competition Assays.
Keyword(s): Chemistry (LCSH) ; Biotechnology (LCSH) ; Medicine (LCSH) ; Biomaterials (LCSH) ; Immunology (LCSH) ; Human physiology (LCSH) ; Diseases (LCSH) ; Vaccines—Biotechnology (LCSH)
; SCOPUS
|
The record appears in these collections: |